LISTEN: Shai Shen-Orr on the Future of Disease Modeling

Shai Shen-Orr on the Future of Disease Modeling

In this newly released podcast, Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion – Israel Institute of Technology, dives into the next frontier of health care: disease modeling. He explains how CytoReason transforms today’s overwhelming biological data into actionable insights that power smarter, faster drug development for leading pharma and biotech companies.

Why This Matters

Shai’s work sits at the heart of a global shift toward data-driven medicine. Disease modeling is reshaping how therapies are discovered, tested, and brought to patients — and Technion researchers like Shai are helping lead that transformation.

Shai serves as the director of the Technion’s Healthy Aging Institute, a multidisciplinary effort uniting researchers to understand the science of aging and extend the years of healthy, active life. His systems-immunology expertise plays a critical role in uncovering how our immune system changes over time, and how science can intervene.

What You’ll Hear About

• What disease modeling is and why it’s becoming essential to modern drug development
• How CytoReason turns massive biological datasets into testable, predictive models
• Real examples of how these models help pharma make quicker, more confident decisions
• The challenges (and opportunities) of the data explosion in biology
• Shai’s perspective on the next decade of computational biology
• How his research connects to broader efforts in healthy aging

Learn More

• Meet Shai Shen-Orr: Explore his research, Technion leadership, and contributions to computational biology
• Healthy Aging at the Technion: Learn how Technion scientists, including Shai, are advancing research to extend years of healthy, active life

Listen to the Episode

Plug in for a fast-paced, insight-packed conversation that brings disease modeling to life. Stream it here.